Expert review of the evidence base for prevention of travelers' diarrhea

Journal of Travel Medicine

Volumn 16, Issue 3, 2009, Pages 149-160

  Dupont, Herbert L ^a,b,c,d   Ericsson, Charles D ^b   Farthing, Michael J G ^e   Gorbach, Sherwood ^f   Pickering, Larry K ^g   Rombo, Lars ^h,i   Steffen, Robert ^j   Weinke, Thomas ^k  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c ST LUKE S EPISCOPAL HOSPITAL   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF BRIGHTON   (United Kingdom)

^f TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h KAROLINSKA INSTITUTE   (Sweden)

ⁱ Sormland County Council   (Sweden)

^j UNIVERSITY OF ZURICH   (Switzerland)

^k KLINIKUM ERNST VON BERGMANN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; BICOZAMYCIN; BISMUTH SALICYLATE; CHOLERA VACCINE; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; ENTEROTOXIGENIC ESCHERICHIA COLI VACCINE; NORFLOXACIN; OFLOXACIN; PLACEBO; PROBIOTIC AGENT; RIFAXIMIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BRAIN DISEASE; CHEMOPROPHYLAXIS; CHOLERA; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG COST; EVIDENCE BASED PRACTICE; FOOD INTAKE; FOOD SAFETY; HUMAN; HYGIENE; IMMUNIZATION; IMMUNOPROPHYLAXIS; LACTOBACILLUS; SACCHAROMYCES BOULARDII; SINGLE DRUG DOSE; TRAVELLER DIARRHEA;

ANTI-BACTERIAL AGENTS; BEVERAGES; DIARRHEA; DRUG RESISTANCE, MICROBIAL; EVIDENCE-BASED MEDICINE; FOOD MICROBIOLOGY; GASTROINTESTINAL AGENTS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PROBIOTICS; TRAVEL; VACCINES;

EID: 65649152030     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2008.00299.x     Document Type: Article

References (120)

1. Gross PA, Barrett TL, Dellinger EP, et al. Purpose of quality standards for infectious diseases. Infectious Diseases Society of America. Clin Infect Dis 1994 18 : 421.
2. Gorbach SL, Kean BH, Evans DG, et al. Travelers' diarrhea and toxigenic Escherichia coli. N Engl J Med 1975 292 : 933 936.
3. Jiang ZD, Mathewson JJ, Ericsson CD, et al. Characterization of enterotoxigenic Escherichia coli strains in patients with traveler's diarrhea acquired in Guadalajara, Mexico, 1992-1997. J Infect Dis 2000 181 : 779 782. (Pubitemid 30131860)
4. Adachi JA, Jiang ZD, Mathewson JJ, et al. Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clin Infect Dis 2001 32 : 1706 1709. (Pubitemid 32531999)
5. Chapin AR, Carpenter CM, Dudley WC, et al. Prevalence of norovirus among visitors from the United States to Mexico and Guatemala who experience traveler's diarrhea. J Clin Microbiol 2005 43 : 1112 1117. (Pubitemid 40364926)
6. Ko G, Garcia C, Jiang ZD, et al. Noroviruses as a cause of traveler's diarrhea among students from the United States visiting Mexico. J Clin Microbiol 2005 43 : 6126 6129. (Pubitemid 43100672)
7. Sanders JW, Putnam SD, Gould P, et al. Diarrheal illness among deployed U.S. military personnel during Operation Bright Star 2001-Egypt. Diagn Microbiol Infect Dis 2005 52 : 85 90. (Pubitemid 40826932)
8. Widdowson MA, Cramer EH, Hadley L, et al. Outbreaks of acute gastroenteritis on cruise ships and on land: identification of a predominant circulating strain of norovirus - United States, 2002. J Infect Dis 2004 190 : 27 36. (Pubitemid 38858401)
9. Jiang ZD, Lowe B, Verenkar MP, et al. Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J Infect Dis 2002 185 : 497 502. (Pubitemid 34142812)
10. Wittlinger F, Steffen R, Watanabe H, Handszuh H. Risk of cholera among Western and Japanese Travelers. J Travel Med 1995 2 : 154 158.
11. Zuckerman JN, Rombo L, Fisch A. The true burden and risk of cholera: implications for prevention and control. Lancet Infect Dis 2007 7 : 521 530. (Pubitemid 47079151)
12. Vargas M, Gascon J, Gallardo F, et al. Prevalence of diarrheagenic Escherichia coli strains detected by PCR in patients with traveler's diarrhea. Clin Microbiol Infect 1998 4 : 682 688. (Pubitemid 29020860)
13. Hoge CW, Shlim DR, Echeverria P, et al. Epidemiology of diarrhea among expatriate residents living in a highly endemic environment. JAMA 1996 275 : 533 538. (Pubitemid 26061428)
14. Shlim DR, Hoge CW, Rajah R, et al. Persistent high risk of diarrhea among foreigners in Nepal during the first 2 years of residence. Clin Infect Dis 1999 29 : 613 616. (Pubitemid 29439962)
15. Taylor DN, Houston R, Shlim DR, et al. Etiology of diarrhea among travelers and foreign residents in Nepal. JAMA 1988 260 : 1245 1248. (Pubitemid 18202888)
16. Haberberger RL Jr., Mikhail IA, Burans JP, et al. Travelers' diarrhea among United States military personnel during joint American-Egyptian armed forces exercises in Cairo, Egypt. Mil Med 1991 156 : 27 30.
17. Taylor DN, Sanchez JL, Candler W, et al. Treatment of travelers' diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial. Ann Intern Med 1991 114 : 731 734.
18. Black RE. Epidemiology of travelers' diarrhea and relative importance of various pathogens. Rev Infect Dis 1990 12 (Suppl 1 S73 S79. (Pubitemid 20060287)
19. Kuschner RA, Trofa AF, Thomas RJ, et al. Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. Clin Infect Dis 1995 21 : 536 541.
20. Riddle MS, Sanders JW, Putnam SD, Tribble DR. Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review. Am J Trop Med Hyg 2006 74 : 891 900. (Pubitemid 46774414)
21. Tribble DR, Sanders JW, Pang LW, et al. Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen. Clin Infect Dis 2007 44 : 338 346. (Pubitemid 46147614)
22. Adachi JA, Mathewson JJ, Jiang ZD, et al. Enteric pathogens in Mexican sauces of popular restaurants in Guadalajara, Mexico, and Houston, Texas. Ann Intern Med 2002 136 : 884 887. (Pubitemid 34625700)
23. Merson MH, Morris GK, Sack DA, et al. Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med 1976 294 : 1299 1305.
24. Tjoa WS, DuPont HL, Sullivan P, et al. Location of food consumption and travelers' diarrhea. Am J Epidemiol 1977 106 : 61 66. (Pubitemid 8160459)
25. Wood LV, Ferguson LE, Hogan P, et al. Incidence of bacterial enteropathogens in foods from Mexico. Appl Environ Microbiol 1983 46 : 328 332.
26. Deetz T, Smith EM, Goyal SM, et al. Occurrence of rota-and enteroviruses in drinking and environmental water in a developing nation. Water Res 1984 18 : 567 571. (Pubitemid 14134170)
27. Vollet JJ, Ericsson CD, Gibson G, et al. Human rotavirus in an adult population with travelers' diarrhea and its relationship to the location of food consumption. J Med Virol 1979 4 : 81 87. (Pubitemid 10231474)
28. Echeverria P, Piyaphong S, Bodhidatta L, et al. Bacterial enteric pathogens in uncooked foods in Thai markets. J Travel Med 1994 1 : 63 67.
29. Sriratanaban A, Reinprayoon S. Vibrio parahaemolyticus: a major cause of travelers' diarrhea in Bangkok. Am J Trop Med Hyg 1982 31 : 128 130. (Pubitemid 12188148)
30. Zhang J, Chang ZR, Zhong HJ, et al. Investigation on status of pollution of vibrio cholera in seafood and aquatic products in 12 provinces of China in 2005. Zhonghua Yu Fang Yi Xue Za Zhi 2007 41 : 208 211.
31. Bandres JC, Mathewson JJ, DuPont HL. Heat susceptibility of bacterial enteropathogens. Implications for the prevention of travelers' diarrhea. Arch Intern Med 1988 148 : 2261 2263. (Pubitemid 18250287)
32. Lynch M, Painter J, Woodruff R, Braden C. Surveillance for foodborne-disease outbreaks - United States, 1998-2002. MMWR Surveill Summ 2006 55 : 1 42.
33. Kozicki M, Steffen R, Schar M. 'Boil it, cook it, peel it or forget it': does this rule prevent travellers' diarrhoea? Int J Epidemiol 1985 14 : 169 172. (Pubitemid 15109506)
34. Shlim DR. Looking for evidence that personal hygiene precautions prevent traveler's diarrhea. Clin Infect Dis 2005 41 (Suppl 8 S531 S535. (Pubitemid 41691582)
35. Steffen R, van der Linde F, Gyr K, Schar M. Epidemiology of diarrhea in travelers. JAMA 1983 249 : 1176 1180. (Pubitemid 13143124)
36. Laverone E, Boccalini S, Bechini A, et al. Travelers' compliance to prophylactic measures and behavior during stay abroad: results of a retrospective study of subjects returning to a travel medicine center in Italy. J Travel Med 2006 13 : 338 344.
37. Ericsson CD, Pickering LK, Sullivan P, DuPont HL. The role of location of food consumption in the prevention of travelers' diarrhea in Mexico. Gastroenterology 1980 79 : 812 816. (Pubitemid 11225990)
38. DuPont HL, Haynes GA, Pickering LK, et al. Diarrhea of travelers to Mexico. Relative susceptibility of United States and Latin American students attending a Mexican University. Am J Epidemiol 1977 105 : 37 41. (Pubitemid 8020093)
39. Steffen R, Tornieporth N, Clemens SA, et al. Epidemiology of travelers' diarrhea: details of a global survey. J Travel Med 2004 11 : 231 237. (Pubitemid 39062177)
40. von Sonnenburg F, Tornieporth N, Waiyaki P, et al. Risk and aetiology of diarrhoea at various tourist destinations. Lancet 2000 356 : 133 134. (Pubitemid 30438516)
41. Thornley JP, Jenkins D, Neal K, et al. Relationship of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome. J Infect Dis 2001 184 : 606 609. (Pubitemid 32783552)
42. Ilnyckyj A, Balachandra B, Elliott L, et al. Post-traveler's diarrhea irritable bowel syndrome: a prospective study. Am J Gastroenterol 2003 98 : 596 599. (Pubitemid 36348531)
43. Okhuysen PC, Jiang ZD, Carlin L, et al. Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterol 2004 99 : 1774 1778. (Pubitemid 39237507)
44. Stermer E, Lubezky A, Potasman I, et al. Is traveler's diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study. Clin Infect Dis 2006 43 : 898 901. (Pubitemid 44435519)
45. Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut 2002 51 : 410 413.
46. Tornblom H, Holmvall P, Svenungsson B, Lindberg G. Gastrointestinal symptoms after infectious diarrhea: a five-year follow-up in a Swedish cohort of adults. Clin Gastroenterol Hepatol 2007 5 : 461 464. (Pubitemid 46575368)
47. Haukka K, Siitonen A. Emerging resistance to newer antimicrobial agents among Shigella isolated from Finnish foreign travellers. Epidemiol Infect 2007 136 : 1 7.
48. Vila J, Vargas M, Ruiz J, et al. Quinolone resistance in enterotoxigenic Escherichia coli causing diarrhea in travelers to India in comparison with other geographical areas. Antimicrob Agents Chemother 2000 44 : 1731 1733. (Pubitemid 30340828)
49. Isenbarger DW, Hoge CW, Srijan A, et al. Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999. Emerg Infect Dis 2002 8 : 175 180. (Pubitemid 34202441)
50. Murphy GS Jr., Echeverria P, Jackson LR, et al. Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in U.S. troops deployed to Thailand in 1994. Clin Infect Dis 1996 22 : 868 869. (Pubitemid 26255621)
51. Saenz Y, Zarazaga M, Lantero M, et al. Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998. Antimicrob Agents Chemother 2000 44 : 267 271. (Pubitemid 30060717)
52. DuPont HL, Jiang ZD, Ericsson CD, et al. Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial. Clin Infect Dis 2001 33 : 1807 1815. (Pubitemid 33105118)
53. DuPont HL, Jiang ZD, Okhuysen PC, et al. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea. Ann Intern Med 2005 142 : 805 812. (Pubitemid 40664039)
54. Taylor DN, Bourgeois AL, Ericsson CD, et al. A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea. Am J Trop Med Hyg 2006 74 : 1060 1066.
55. de dios Pozo-Olano J, Warram JH Jr., Gomez RG, Cavazos MG. Effect of a lactobacilli preparation on traveler's diarrhea. A randomized, double blind clinical trial. Gastroenterology 1978 74 : 829 830. (Pubitemid 8332334)
56. Sack DA, Kaminsky DC, Sack RB, et al. Prophylactic doxycycline for travelers' diarrhea. Results of a prospective double-blind study of Peace Corps volunteers in Kenya. N Engl J Med 1978 298 : 758 763. (Pubitemid 9191945)
57. Sack RB, Froehlich JL, Zulich AW, et al. Prophylactic doxycycline for travelers' diarrhea: results of a prospective double-blind study of Peace Corps volunteers in Morocco. Gastroenterology 1979 76 : 1368 1373. (Pubitemid 9191945)
58. DuPont HL, Sullivan P, Evans DG, et al. Prevention of traveler's diarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth. JAMA 1980 243 : 237 241. (Pubitemid 10201603)
59. DuPont HL, Evans DG, Rios N, et al. Prevention of travelers' diarrhea with trimethoprim-sulfamethoxazole. Rev Infect Dis 1982 4 : 533 539.
60. DuPont HL, Galindo E, Evans DG, et al. Prevention of travelers' diarrhea with trimethoprim-sulfamethoxazole and trimethoprim alone. Gastroenterology 1983 84 : 75 80. (Pubitemid 13198292)
61. Sack RB, Santosham M, Froehlich JL, et al. Doxycycline prophylaxis of travelers' diarrhea in Honduras, an area where resistance to doxycycline is common among enterotoxigenic Escherichia coli. Am J Trop Med Hyg 1984 33 : 460 466. (Pubitemid 14075648)
62. Ericsson CD, DuPont HL, Galindo E, et al. Efficacy of bicozamycin in preventing traveler's diarrhea. Gastroenterology 1985 88 : 473 477. (Pubitemid 15194712)
63. Johnson PC, Ericsson CD, Morgan DR, et al. Lack of emergence of resistant fecal flora during successful prophylaxis of traveler's diarrhea with norfloxacin. Antimicrob Agents Chemother 1986 30 : 671 674. (Pubitemid 17187691)
64. DuPont HL, Ericsson CD, Johnson PC, et al. Prevention of travelers' diarrhea by the tablet formulation of bismuth subsalicylate. JAMA 1987 257 : 1347 1350. (Pubitemid 17024853)
65. Wistrom J, Norrby SR, Burman LG, et al. Norfloxacin versus placebo for prophylaxis against travellers' diarrhoea. J Antimicrob Chemother 1987 20 : 563 574. (Pubitemid 17154598)
66. Scott DA, Haberberger RL, Thornton SA, Hyams KC. Norfloxacin for the prophylaxis of travelers' diarrhea in U.S. military personnel. Am J Trop Med Hyg 1990 42 : 160 164. (Pubitemid 20093449)
67. Rademaker CM, Hoepelman IM, Wolfhagen MJ, et al. Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers' diarrhea. Eur J Clin Microbiol Infect Dis 1989 8 : 690 694. (Pubitemid 19207157)
68. Kollaritsch H, Holst H, Grobara P, Wiedermann G. Prevention of traveler's diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study. Fortschr Med 1993 111 : 152 156. (Pubitemid 23140419)
69. Hilton E, Kolakowski P, Singer C, Smith M. Efficacy of Lactobacillus GG as a Diarrheal Preventive in Travelers. J Travel Med 1997 4 : 41 43. (Pubitemid 27200255)
70. Briand V, Buffet P, Genty S, et al. Absence of efficacy of nonviable Lactobacillus acidophilus for the prevention of traveler's diarrhea: a randomized, double-blind, controlled study. Clin Infect Dis 2006 43 : 1170 1175. (Pubitemid 44632801)
71. DuPont HL, Ericsson CD, Jiang Z-D, et al. Prevention of travelers' diarrhea with rifaximin: a phase 3, randomized, double-blind, placebo-controlled trial in US students in Mexico. 71st Annual Meeting of the American College of Gastroenterology ; 2006; Las Vegas, NV. Abstract 516.
72. Kean BH. The diarrhea of travelers to Mexico. Summary of five-year study. Ann Intern Med 1963 59 : 605 614.
73. Kean BH, Schaffner W, Brennan RW. The diarrhea of travelers. V. Prophylaxis with phthalylsulfathiazole and neomycin sulphate. JAMA 1962 180 : 367 371.
74. Gomi H, Jiang ZD, Adachi JA, et al. In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions. Antimicrob Agents Chemother 2001 45 : 212 216. (Pubitemid 32039117)
75. Gorbach S, Edelman R. Traveler's diarrhea: national Institutes of Health Consensus Development Conference. Rev Infect Dis 1986 8 (Suppl 2 S109 S233.
76. Reves RR, Johnson PC, Ericsson CD, DuPont HL. A cost-effectiveness comparison of the use of antimicrobial agents for treatment or prophylaxis of travelers' diarrhea. Arch Intern Med 1988 148 : 2421 2427. (Pubitemid 18273075)
77. Farthing MJ, DuPont HL, Guandalini S, et al. Treatment and prevention of Travellers' diarrhoea. Gastroenterol Int 1992 5 : 162 175. (Pubitemid 17124123)
78. DuPont HL, Ericsson CD. Prevention and treatment of traveler's diarrhea. N Engl J Med 1993 328 : 1821 1827. (Pubitemid 23332457)
79. Campbell EA, Korzheva N, Mustaev A, et al. Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 2001 104 : 901 912. (Pubitemid 32289282)
80. DuPont HL, Jiang ZD. Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci. Clin Microbiol Infect 2004 10 : 1009 1011. (Pubitemid 39562470)
81. Taylor DN, McKenzie R, Durbin A, et al. Rifaximin, a nonabsorbed oral antibiotic, prevents shigellosis after experimental challenge. Clin Infect Dis 2006 42 : 1283 1288.
82. Hill DR, Ericsson CD, Pearson RD, et al. The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006 43 : 1499 1539.
83. Sierra JM, Ruiz J, Navia MM, et al. In vitro activity of rifaximin against enteropathogens producing traveler's diarrhea. Antimicrob Agents Chemother 2001 45 : 643 644. (Pubitemid 32105314)
84. Graham DY, Estes MK, Gentry LO. Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli-induced diarrhea in volunteers. Gastroenterology 1983 85 : 1017 1022.
85. Steffen R, DuPont HL, Heusser R, et al. Prevention of traveler's diarrhea by the tablet form of bismuth subsalicylate. Antimicrob Agents Chemother 1986 29 : 625 627. (Pubitemid 16106384)
86. Pickering LK, Feldman S, Ericsson CD, Cleary TG. Absorption of salicylate and bismuth from a bismuth subsalicylate-containing compound (Pepto-Bismol). J Pediatr 1981 99 : 654 656. (Pubitemid 12232116)
87. Gordon MF, Abrams RI, Rubin DB, et al. Bismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonus. Mov Disord 1995 10 : 220 222.
88. Hasking GJ, Duggan JM. Encephalopathy from bismuth subsalicylate. Med J Aust 1982 2 : 167.
89. Jungreis AC, Schaumburg HH. Encephalopathy from abuse of bismuth subsalicylate (Pepto-Bismol). Neurology 1993 43 : 1265. (Pubitemid 23177741)
90. Mendelowitz PC, Hoffman RS, Weber S. Bismuth absorption and myoclonic encephalopathy during bismuth subsalicylate therapy. Ann Intern Med 1990 112 : 140 141. (Pubitemid 20022695)
91. Levine MM, Hornick RB. Lactulose therapy in Shigella carrier state and acute dysentery. Antimicrob Agents Chemother 1975 8 : 581 584.
92. Oksanen PJ, Salminen S, Saxelin M, et al. Prevention of travellers' diarrhoea by Lactobacillus GG. Ann Med 1990 22 : 53 56. (Pubitemid 20110832)
93. McFarland LV. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis 2007 5 : 97 105. (Pubitemid 46222221)
94. Paton AW, Jennings MP, Morona R, et al. Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea. Gastroenterology 2005 128 : 1219 1228. (Pubitemid 40712174)
95. Parashar UD, Alexander JP, Glass RI. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006 55 : 1 13.
96. Clemens JD, Harris JR, Sack DA, et al. Field trial of oral cholera vaccines in Bangladesh: results of one year of follow-up. J Infect Dis 1988 158 : 60 69. (Pubitemid 18189001)
97. Peltola H, Siitonen A, Kyronseppa H, et al. Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine. Lancet 1991 338 : 1285 1289.
98. Scerpella EG, Sanchez JL, Mathewson IJ, et al. Safety, immunogenicity, and protective efficacy of the whole-cell/recombinant B subunit (WC/rBS) oral cholera vaccine against travelers' diarrhea. J Travel Med 1995 2 : 22 27.
99. Clemens JD, Sack DA, Harris JR, et al. Field trial of oral cholera vaccines in Bangladesh. Lancet 1986 2 : 124 127. (Pubitemid 16098257)
100. Clemens JD, Sack DA, Harris JR, et al. Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. J Infect Dis 1988 158 : 372 377. (Pubitemid 18223254)
101. Clemens J, Savarino S, Abu-Elyazeed R, et al. Development of pathogenicity-driven definitions of outcomes for a field trial of a killed oral vaccine against enterotoxigenic Escherichia coli in Egypt: application of an evidence-based method. J Infect Dis 2004 189 : 2299 2307. (Pubitemid 38757204)
102. Hall ER, Wierzba TF, Ahren C, et al. Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine. Infect Immun 2001 69 : 2853 2857. (Pubitemid 32332174)
103. Jertborn M, Ahren C, Holmgren J, Svennerholm AM. Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine. Vaccine 1998 16 : 255 260. (Pubitemid 27521007)
104. Sack DA, Shimko J, Torres O, et al. Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. coli diarrhoea of travellers to Guatemala and Mexico. Vaccine 2007 25 : 4392 4400. (Pubitemid 46691284)
105. Yu J, Cassels F, Scharton-Kersten T, et al. Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli. Infect Immun 2002 70 : 1056 1068. (Pubitemid 34163374)
106. Guerena-Burgueno F, Hall ER, Taylor DN, et al. Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously. Infect Immun 2002 70 : 1874 1880. (Pubitemid 34242187)
107. Glenn GM, Villar CP, Flyer DC, et al. Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum. Infect Immun 2007 75 : 2163 2170. (Pubitemid 46744302)
108. McKenzie R, Bourgeois AL, Frech SA, et al. Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study. Vaccine 2007 25 : 3684 3691. (Pubitemid 46584755)
109. Frech SA, DuPont HL, Bourgeois AL, et al. Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomized, double-blind, placebo-controlled field trial. Lancet 2008 371 : 2019 2025.
110. Caeiro JP, Estrada-Garcia MT, Jiang ZD, et al. Improved detection of enterotoxigenic Escherichia coli among patients with travelers' diarrhea, by use of the polymerase chain reaction technique. J Infect Dis 1999 180 : 2053 2055.
111. Iijima Y, Tanaka S, Miki K, et al. Evaluation of colony-based examinations of diarrheagenic Escherichia coli in stool specimens: low probability of detection because of low concentrations, particularly during the early stage of gastroenteritis. Diagn Microbiol Infect Dis 2007 58 : 303 308 (Pubitemid 47017649)
112. Gorbach SL. How to hit the runs for fifty million travelers at risk. Ann Intern Med 2005 142 : 861 862. (Pubitemid 40664046)
113. Jiang ZD, Okhuysen PC, Guo DC, et al. Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. J Infect Dis 2003 188 : 506 511. (Pubitemid 37011801)
114. Mohamed JA, DuPont HL, Jiang ZD, et al. A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico. Clin Infect Dis 2007 44 : 945 952. (Pubitemid 46452059)
115. Nalin DR, Levine RJ, Levine MM, et al. Cholera, non-vibrio cholera, and stomach acid. Lancet 1978 2 : 856 859.
116. Sack GH Jr., Pierce NF, Hennessey KN, et al. Gastric acidity in cholera and noncholera diarrhoea. Bull World Health Organ 1972 47 : 31 36.
117. Van Loon FP, Clemens JD, Shahrier M, et al. Low gastric acid as a risk factor for cholera transmission: application of a new non-invasive gastric acid field test. J Clin Epidemiol 1990 43 : 1361 1367.
118. Weinke T, Liebold I, Burchard GD, et al. Prophylactic immunization against enterotoxin-forming Escherichia coli travellers' diarrhea and cholera: does it make sense and for whom? Dtsch Med Wochenschr 2006 131 : 1660 1664. (Pubitemid 44542691)
119. Ashley DV, Walters C, Dockery-Brown C, et al. Interventions to prevent and control food-borne diseases associated with a reduction in traveler's diarrhea in tourists to Jamaica. J Travel Med 2004 11 : 364 367. (Pubitemid 39627091)
120. Steffen R, Collard F, Tornieporth N, et al. Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica. JAMA 1999 281 : 811 817. (Pubitemid 29113741)